Triamcinolone Acetonide
Brand name: Triamcinolone Acetonide
Rank #351 of 500 drugs by total cost
$28.5M
Total Cost
2,307,130
Total Claims
$28.5M
Total Cost
60,895
Prescribers
$12
Cost per Claim
1,285,009
Beneficiaries
2,561,504
30-Day Fills
$467
Avg Cost/Provider
38
Avg Claims/Provider
About Triamcinolone Acetonide
Triamcinolone Acetonide (sold as Triamcinolone Acetonide) was prescribed 2,307,130 times by 60,895 Medicare Part D providers in 2023, costing the program $28.5M. At $12 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 348 | Cyclobenzaprine Hcl (Cyclobenzaprine Hcl) | $28.7M | 2,582,519 |
| 349 | Atenolol (Atenolol) | $28.6M | 2,717,988 |
| 350 | Meloxicam (Meloxicam) | $28.6M | 4,714,084 |
| 351 | Triamcinolone Acetonide (Triamcinolone Acetonide) | $28.5M | 2,307,130 |
| 352 | Pitolisant Hcl (Wakix) | $28.4M | 2,361 |
| 353 | Olanzapine/Samidorphan Malate (Lybalvi) | $28.3M | 18,294 |
| 354 | Interferon Beta-1b (Betaseron) | $28.3M | 2,983 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology